Hypothetical $10,000 invested at their first disclosed trade date. · log scale
Hypothetical backtest based on disclosed trades. Past performance does not predict future results. Not investment advice.
| Ticker | Action | Description | Traded |
|---|---|---|---|
| NVDA | Buy | NVIDIA Corporation | Jun 26, 2026 |
| NVDA | Buy | NVIDIA Corporation | Jun 26, 2026 |
| NVDA | Buy | NVIDIA Corporation | Jun 26, 2026 |
| GOOG | Buy | Alphabet Inc. | Jun 15, 2026 |
| MSFT | Buy | Microsoft Corporation | Jun 11, 2026 |
| MSFT | Buy | Microsoft Corporation | Jun 11, 2026 |
| QNT | Buy | Quantinuum Inc. | Jun 4, 2026 |
| AAPL | Buy | Apple Inc. | May 14, 2026 |
| TSM | Buy | Taiwan Semiconductor Manufac | Apr 9, 2026 |
| GOOG | Buy | Alphabet Inc. | Mar 16, 2026 |
Cleo Fields is a United States Representative from LA affiliated with the Democratic Party, serving in the US House of Representatives. Disclosed Capitol tracks 207 disclosed stock trades from Cleo Fields, filed under the STOCK Act. The portfolio compounds at 13.2% annualized — 0.2% above the S&P 500 benchmark over the same period, with a 62% win rate on individual trades. The full trade history, holdings, sector allocation, and risk metrics are below.
Cleo Fields (D-LA) has disclosed 207 trades under the STOCK Act; portfolio CAGR of 13.2% (+0.2% vs. the S&P 500); top tickers traded: NVDA, GOOG, AAPL.
Full trade list with transaction dates, disclosure dates, tickers, and amount ranges is in the interactive table below.
Most-traded tickers: NVDA, GOOG, AAPL. Sector allocation and portfolio weighting appear in the Holdings panel.
Annualized return: 13.2% CAGR, +0.2% alpha vs. the S&P 500. Detailed performance charts are in the Performance panel.
Cleo Fields's disclosed stock portfolio is valued at approximately $23.5M across 25 tracked positions. This reflects only publicly disclosed, exchange-traded securities from STOCK Act filings — it excludes real estate, private assets, cash, and liabilities, so it is a partial floor on Cleo Fields's total net worth, not a complete measure of it.